Open AccessCharacterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort
Author(s) -
George Khoudari,
Amandeep Singh,
Mazen Noureddin,
Danielle Fritze,
Rocío López,
Imad Asaad,
Eric Lawitz,
Fred Poordad,
Kris V. Kowdley,
Naim Alkhouri
Publication year - 2019
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v11.i10.710
Subject(s) - medicine , nonalcoholic fatty liver disease , fatty liver , gastroenterology , metabolic syndrome , steatosis , cohort , overweight , diabetes mellitus , population , body mass index , alanine transaminase , type 2 diabetes , national health and nutrition examination survey , obesity , disease , endocrinology , environmental health
Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS) and is characterized by steatosis in the absence of significant alcohol consumption. However, MetS and significant alcohol intake coexist in certain individuals which may lead to the development of BAFLD.